2012 Global Toxoplasmosis Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country

April 2012 | 226 pages | ID: GD62DB7C161EN
Venture Planning Group

Abstracts

The report presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Toxoplasmosis definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

• Hospitals
• Commercial/Private Labs
• Physician Offices
• Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Toxoplasmosis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 226 pages and 15 tables.

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
  Abbott AxSYM
  Abbott IMx/IMx Select
  Anagen AN2000/AuraFlex
  Beckman Coulter Access
  BioChem Pharma/SR1
  BioMerieux/Vitek Vidas
  Biotrol System 7000
  Chiron ACS: Centaur
  Chiron ACS: 180
  J&J Diagnostics/Amersham Amerlite
  J&J Diagnostics Vitros ECi
  Olympus PK310
  Roche Cobas Core
  Roche Elecsys 1010/2010
  Roche ES 22
  Roche ES 33
  Roche ES 300/300AL
  Siemens ELISA Processor II/III
  Siemens Immuno 1
  Siemens/Opus/Plus/Magnum
  Siemens Stratus
  Tosoh AIA-1200/1200DX/NexIA/600
  Wallac/Pharmacia Delfia
E. Emerging Diagnostic Technologies
  1. DNA Probes
    a. Technology Overview
    b. Amplification Methods
      Polymerase Chain Reaction
        Robotics
        Temperature Cyclers
        PCR Variations
      Immuno-PCR
      QC-PCR
      DAP-PCR
      Ligase Chain Reaction
      Branched DNA
      Q-Beta Replicase
      Nucleic-Acid Sequence-Based
      Strand Displacement Activation
      Self-Sustained Sequence Replicase
  2. Monoclonal Antibodies
  3. Immunoassays
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      Dot Immunobinding Assays
      Capillary Immunoassays
      Particle-Membrane Capture Immunoassays
      Enzyme Amplification
    c. Fluorescent Immunoassays
      Fluorescence Polarization
      Time-Resolved Pulse Fluorescence
    d. Luminescence
      Chemiluminescence
      Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Differential Light Scattering
  5. Microcomputers and Automation
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. MRI
  11. Gel Microdroplets
  12. Other

III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

V. ITALY: TEST MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

  Abbott
  Affymetrix
  Applera
  Beckman Coulter
  Becton Dickinson
  Binding Site
  Biomerica
  Biokit
  bioMerieux
  Bio-Rad
  Biotrol
  Biosite
  Biotest
  Caliper Technologies
  Cepheid
  Chemicon
  Daiichi
  DiaSorin
  Diagast
  Diamedix
  Digene
  Eiken
  Enzo Biochem
  Fujirebio
  GenBio
  Gene-Tec
  Hemagen
  Immunetics
  Innogenetics
  Inverness
  J&J
  Meridian
  Nanogen
  Nissui
  Olympus
  Provalis
  Roche
  Saliva Diagnostic
  SeraCare
  Siemens
  Third Wave Technologies
  Thermo Fisher
  Tosho
  Trinity Biotech
  Tropix
  Wampole Labs
  Zenith
  Zeus

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Toxoplasmosis Tests
France Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Germany Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Italy Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Japan Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Spain Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
U.K. Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier